YB
YB: Yue Ying discloses securities transactions
Yue Ying reported Grant or award in Yuanbao Inc.: 90000 units of Options (Right to Buy) (derivative), dated 2026-09-16. The full Form 4 contains 5 transaction entries.
LoadingLoadingLoadingYB
Yue Ying reported Grant or award in Yuanbao Inc.: 90000 units of Options (Right to Buy) (derivative), dated 2026-09-16. The full Form 4 contains 5 transaction entries.
VITL
Van Hoven Reena Chauhan reported Tax/exercise withholding in Vital Farms, Inc.: 344 units of Common Stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
TH
Schrenk Troy C. reported Purchase in Target Hospitality Corp.: 5907 units of Common Stock, par value $0.001 per share, dated 2026-09-18. The full Form 4 contains 1 transaction entry.
UBER
West Tony reported Exercise or conversion in Uber Technologies, Inc: 1511.00 units of Common Stock, dated 2026-09-16. The full Form 4 contains 12 transaction entries.
SNGX
ZELDIS JEROME B reported Grant or award in SOLIGENIX, INC.: 78947 units of Stock Option (Right to Buy) (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
SCHL
Walker Verdell reported 3,700 shares of Common Stock in SCHOLASTIC CORP as grants or awards dated 2026-09-16. The Form 4 was disclosed on Sep 18, 2026. These were stock awards, not open-market purchases.
RVTY
Vohra Tajinder S reported Sale in REVVITY, INC.: 7330 units of Common Stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
SCHL
Wolff Anne Clarke reported 3,700 shares of Common Stock in SCHOLASTIC CORP as grants or awards dated 2026-09-16. The Form 4 was disclosed on Sep 18, 2026. These were stock awards, not open-market purchases.
PRLB
Schumacher Daniel reported Sale in Proto Labs Inc: 100 units of Common Stock, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
SION
Ridloff Elena reported Grant or award in Sionna Therapeutics, Inc.: 47269 units of Common Stock, dated 2026-09-17. The full Form 4 contains 4 transaction entries.
SNGX
RUBIN ROBERT J. reported Grant or award in SOLIGENIX, INC.: 78947 units of Stock Option (Right to Buy) (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
QUIK
SAXE TIMOTHY reported Sale in QUICKLOGIC Corp: 10364 units of Common Stock, dated 2026-09-17. The full Form 4 contains 1 transaction entry.
PJT
Travin David Adam reported Grant or award in PJT Partners Inc.: 12 units of Restricted Stock Units (derivative), dated 2026-09-16. The full Form 4 contains 1 transaction entry.
SNGX
Parks Diane L. reported Grant or award in SOLIGENIX, INC.: 78947 units of Stock Option (Right to Buy) (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
PJT
Whitney Kenneth C reported Grant or award in PJT Partners Inc.: 9 units of Restricted Stock Units (derivative), dated 2026-09-16. The full Form 4 contains 1 transaction entry.
PJT
Skaugen Grace Reksten reported Grant or award in PJT Partners Inc.: 9 units of Restricted Stock Units (derivative), dated 2026-09-16. The full Form 4 contains 1 transaction entry.
PJT
Rafferty Emily K reported Grant or award in PJT Partners Inc.: 9 units of Restricted Stock Units (derivative), dated 2026-09-16. The full Form 4 contains 1 transaction entry.
XOS
OSTERMANN DIETMAR reported Sale in Xos, Inc.: 262 units of Common Stock, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
WMT
Nicholas Christopher James reported Sale in Walmart Inc.: 1505 units of Common, dated 2026-09-17. The full Form 4 contains 2 transaction entries.
QUIK
Nader Elias reported Sale in QUICKLOGIC Corp: 8291 units of Common Stock, dated 2026-09-17. The full Form 4 contains 1 transaction entry.
MRLN
Ravestein Leslie Renee reported Tax/exercise withholding in Merlin, Inc.: 1101 units of Common stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
SION
McKee Charlotte reported Grant or award in Sionna Therapeutics, Inc.: 50000 units of Common Stock, dated 2026-09-17. The full Form 4 contains 4 transaction entries.
PL
Marshall William Spencer reported Gift in Planet Labs PBC: 80000 units of Class A Common Stock, dated 2026-09-18. The full Form 4 contains 1 transaction entry.
UTHR
MAHON PAUL A reported Exercise or conversion in UNITED THERAPEUTICS Corp: 8300.00 units of Common Stock, dated 2026-09-17. The full Form 4 contains 9 transaction entries.
